You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 20, 2024

Cosette Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for COSETTE, and what generic and branded alternatives to COSETTE drugs are available?

COSETTE has one hundred and seventeen approved drugs.



Summary for Cosette
US Patents:0
Tradenames:68
Ingredients:64
NDAs:117

Drugs and US Patents for Cosette

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cosette CAPTOPRIL captopril TABLET;ORAL 074462-002 Feb 13, 1996 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Cosette ACEPHEN acetaminophen SUPPOSITORY;RECTAL 072218-001 Mar 27, 1992 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Cosette NYSTATIN nystatin CREAM;TOPICAL 061966-001 Approved Prior to Jan 1, 1982 AT RX No No ⤷  Try a Trial ⤷  Try a Trial
Cosette CAPTOPRIL captopril TABLET;ORAL 074483-002 Feb 13, 1996 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Cosette METRONIDAZOLE metronidazole CREAM;TOPICAL 077549-001 Dec 19, 2007 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Cosette

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Cosette WELCHOL colesevelam hydrochloride TABLET;ORAL 021176-001 May 26, 2000 5,607,669*PED ⤷  Try a Trial
Cosette AZOR amlodipine besylate; olmesartan medoxomil TABLET;ORAL 022100-001 Sep 26, 2007 5,616,599*PED ⤷  Try a Trial
Cosette TRIBENZOR amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil TABLET;ORAL 200175-001 Jul 23, 2010 5,616,599*PED ⤷  Try a Trial
Cosette EFFIENT prasugrel hydrochloride TABLET;ORAL 022307-001 Jul 10, 2009 8,404,703*PED ⤷  Try a Trial
Cosette WELCHOL colesevelam hydrochloride FOR SUSPENSION;ORAL 022362-002 Oct 2, 2009 5,607,669*PED ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for COSETTE drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Tablets 10 mg/20 mg and 5 mg/40 mg ➤ Subscribe 2008-03-31
➤ Subscribe Tablets 20 mg/12.5 mg ➤ Subscribe 2007-05-11
➤ Subscribe Tablets 5 mg and 10 mg ➤ Subscribe 2013-07-10
➤ Subscribe Powder for Oral Suspension 1.875 g/Packet and 3.75 g/Packet ➤ Subscribe 2010-04-09
➤ Subscribe Tablets 5 mg/20 mg and 10 mg/40 mg ➤ Subscribe 2008-02-11
➤ Subscribe Tablets 5 mg, 20 mg and 40 mg ➤ Subscribe 2006-04-25
➤ Subscribe Tablets 40 mg/12.5 mg and 40 mg/25 mL ➤ Subscribe 2007-02-15
➤ Subscribe Tablets 625 mg ➤ Subscribe 2009-07-01
➤ Subscribe Capsules 30 mg ➤ Subscribe 2009-02-27
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.